Oncology & Cancer

Ovarian cancer: Potential therapeutic target identified

A gene called DOT1L appears to play a role in progression and severity of ovarian cancer, and inhibitors of the DOT1L enzyme may offer a new therapeutic approach for the disease, University of Alabama at Birmingham researchers ...

Oncology & Cancer

CRISPR study lays groundwork for overcoming ovarian cancer

A team of researchers at the University of Colorado Anschutz Medical Campus has gained attention for their work on rethinking ovarian cancer disease progression and treatment. Equipped with highly advanced technology, they ...

Oncology & Cancer

Lymphadenectomy does not up survival in advanced ovarian cancer

(HealthDay)—For patients with advanced ovarian cancer who have undergone intra-abdominal macroscopically complete resection and have clinically negative lymph nodes, lymphadenectomy is not associated with longer overall ...

page 2 from 4